MSD KK - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH79618D
- Pages: 22
- September 2018
- Total Views:1138
- Region : Asia
- GlobalData
- Equity Research Report

Details
Summary
MSD KK (MSD), formerly Nippon Organon KK, is a subsidiary of Merck & Co Inc, is a distributor of medical drugs and vaccines. The company offers prescription drugs and vaccines including biologic therapies, consumer care and animal health products. Its research and development division develops new medicines, and offers plans for development of new drugs by providing early information. MSD's production division produces safe medicines; and sales and marketing division delivers pharmaceuticals data. The company also offers information on diseases and treatments through several media such as the Internet to doctors, pharmacists and medicine wholesalers, and others. It offers products in various therapeutic areas including diabetes, cardiovascular, respiratory, hepatitis, central nervous system, anesthesiology, cancer, women's health and ophthalmic diseases. The company operates through its branch office and factory located in Osaka and Menuma, Japan. MSD is headquartered in Tokyo, Japan.
MSD KK-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MSD KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MSD KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MSD KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MSD KK, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MSD Enters into Distribution Agreement with Kyorin Pharma 10
Astellas Pharma Enters into Co-Promotion Agreement with MSD 11
CMIC Enters into Agreement with MSD for Diazoxide 12
MSD Enters into Agreement with Kyorin Pharma 13
Kyorin Pharma Amends Co-Marketing Agreement with MSD 14
Astellas Pharma Enters Into Co-Promotion Agreement With MSD For Ipragliflozin 15
MSD Enters Into Distribution Agreement With Julphar 16
Licensing Agreements 17
Meiji Seika Pharma Enters into Licensing Agreement with MSD 17
Asset Transactions 18
Kyorin Acquires Production Facility from MSD 18
MSD KK-Key Competitors 19
MSD KK-Key Employees 20
MSD KK-Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List Of Figure
List of Figures
MSD KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MSD KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
MSD KK, Pharmaceuticals & Healthcare, Key Facts 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MSD KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD KK, Deals By Therapy Area, 2012 to YTD 2018 8
MSD KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MSD Enters into Distribution Agreement with Kyorin Pharma 10
Astellas Pharma Enters into Co-Promotion Agreement with MSD 11
CMIC Enters into Agreement with MSD for Diazoxide 12
MSD Enters into Agreement with Kyorin Pharma 13
Kyorin Pharma Amends Co-Marketing Agreement with MSD 14
Astellas Pharma Enters Into Co-Promotion Agreement With MSD For Ipragliflozin 15
MSD Enters Into Distribution Agreement With Julphar 16
Meiji Seika Pharma Enters into Licensing Agreement with MSD 17
Kyorin Acquires Production Facility from MSD 18
MSD KK, Key Competitors 19
MSD KK, Key Employees 20
MSD KK, Other Locations 21
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
MSD KK, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
MSD KK (MSD), formerly Nippon Organon KK, is a subsidiary of Merck & Co Inc, is a distributor of medical drugs and vaccines. The company offers prescription drugs and vaccines including biologic therapies, consumer care and animal health products. Its research and development division develops new medicines, and offers plans for development of new drugs by providing early information. MSD's production division produces safe medicines; and sales and marketing division delivers pharmaceuticals data. The company also offers information on diseases and treatments through several media such as the Internet to doctors, pharmacists and medicine wholesalers, and others. It offers products in various therapeutic areas including diabetes, cardiovascular, respiratory, hepatitis, central nervous system, anesthesiology, cancer, women's health and ophthalmic diseases. The company operates through its branch office and factory located in Osaka and Menuma, Japan. MSD is headquartered in Tokyo, Japan.
MSD KK-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MSD KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MSD KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MSD KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MSD KK, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
MSD Enters into Distribution Agreement with Kyorin Pharma 10
Astellas Pharma Enters into Co-Promotion Agreement with MSD 11
CMIC Enters into Agreement with MSD for Diazoxide 12
MSD Enters into Agreement with Kyorin Pharma 13
Kyorin Pharma Amends Co-Marketing Agreement with MSD 14
Astellas Pharma Enters Into Co-Promotion Agreement With MSD For Ipragliflozin 15
MSD Enters Into Distribution Agreement With Julphar 16
Licensing Agreements 17
Meiji Seika Pharma Enters into Licensing Agreement with MSD 17
Asset Transactions 18
Kyorin Acquires Production Facility from MSD 18
MSD KK-Key Competitors 19
MSD KK-Key Employees 20
MSD KK-Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List Of Figure
List of Figures
MSD KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD KK, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MSD KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD KK, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List Of Table
List of Tables
MSD KK, Pharmaceuticals & Healthcare, Key Facts 2
MSD KK, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MSD KK, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MSD KK, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MSD KK, Deals By Therapy Area, 2012 to YTD 2018 8
MSD KK, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MSD Enters into Distribution Agreement with Kyorin Pharma 10
Astellas Pharma Enters into Co-Promotion Agreement with MSD 11
CMIC Enters into Agreement with MSD for Diazoxide 12
MSD Enters into Agreement with Kyorin Pharma 13
Kyorin Pharma Amends Co-Marketing Agreement with MSD 14
Astellas Pharma Enters Into Co-Promotion Agreement With MSD For Ipragliflozin 15
MSD Enters Into Distribution Agreement With Julphar 16
Meiji Seika Pharma Enters into Licensing Agreement with MSD 17
Kyorin Acquires Production Facility from MSD 18
MSD KK, Key Competitors 19
MSD KK, Key Employees 20
MSD KK, Other Locations 21
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
MSD KK, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.